ARTICLE | Clinical News
Yosprala 325/40 regulatory update
September 19, 2016 7:00 AM UTC
FDA approved an NDA from Aralez for Yosprala 325/40 (PA32540) and Yosprala 81/40 ( PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcer...